FDA approves drug for sexual desires disorders in women
On Aug. 18, the U.S. Food and Drug Administration (FDA) approved Addyi (flibanserin) to treat acquired, generalized hypoactive sexual desire disorder in premenopausal women.…
Women’s Health
Sexual assault screening in the outpatient setting
Every 2 minutes, someone in the United States experiences a sexual assault. Sexual assault encompasses a number of acts ranging from inappropriate exposure or…
FDA approves Ibrance for postmenopausal women with metastatic breast cancer
On February 3, the U.S. Food and Drug Administration (FDA) approved Ibrance (palbociclib) to treat advanced metastatic breast cancer. Read more.
Reducing barriers to glucose control in patients with gestational diabetes
According to the Centers for Disease Control and Prevention (CDC), 9.2% of pregnant women develop gestational diabetes mellitus (GDM) as a serious complication during…
Stemming the tide of alcohol abuse in women
Whatever your specialty or work setting, you’re sure to encounter women who use or abuse alcohol. An estimated 5.3 million women in the United…
Study: More focus on maternal mental health needed
Maternal depression is more common at 4 years following childbirth than at any other time in the first 12 months after childbirth, according to…
Study: Premature menopause may affect later-life cognition
Premature menopause is associated with long-term negative effects on cognitive function, suggests a study in BJOG: An International Journal of Obstetrics and Gynaecology. Compared…
Benefits of exercise training in heart failure
Exercise training reduces the risk for subsequent all-cause mortality or all-cause hospitalization in women by 26%, compared with 10% in men, according to a…
Study: Gestational diabetes may increase risk for atherosclerosis later in midlife
Pregnant women who develop gestational diabetes may be at risk for early atherosclerosis during midlife before the onset of diabetes and metabolic diseases, according…
FDA approves drug for sexual desires disorders in women
On Aug. 18, the U.S. Food and Drug Administration (FDA) approved Addyi (flibanserin) to treat acquired, generalized hypoactive sexual desire disorder in…
Sexual assault screening in the outpatient setting
Every 2 minutes, someone in the United States experiences a sexual assault. Sexual assault encompasses a number of acts ranging from inappropriate…
FDA approves Ibrance for postmenopausal women with metastatic breast cancer
On February 3, the U.S. Food and Drug Administration (FDA) approved Ibrance (palbociclib) to treat advanced metastatic breast cancer. Read more.
Reducing barriers to glucose control in patients with gestational diabetes
According to the Centers for Disease Control and Prevention (CDC), 9.2% of pregnant women develop gestational diabetes mellitus (GDM) as a serious…
Stemming the tide of alcohol abuse in women
Whatever your specialty or work setting, you’re sure to encounter women who use or abuse alcohol. An estimated 5.3 million women in…
Study: More focus on maternal mental health needed
Maternal depression is more common at 4 years following childbirth than at any other time in the first 12 months after childbirth,…
Study: Premature menopause may affect later-life cognition
Premature menopause is associated with long-term negative effects on cognitive function, suggests a study in BJOG: An International Journal of Obstetrics and…
Benefits of exercise training in heart failure
Exercise training reduces the risk for subsequent all-cause mortality or all-cause hospitalization in women by 26%, compared with 10% in men, according…
Study: Gestational diabetes may increase risk for atherosclerosis later in midlife
Pregnant women who develop gestational diabetes may be at risk for early atherosclerosis during midlife before the onset of diabetes and metabolic…
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.